Cargando…
Dominant Antiviral CD8(+) T Cell Responses Empower Prophylactic Antibody-Eliciting Vaccines Against Cytomegalovirus
Human cytomegalovirus (HCMV) is an ubiquitous herpesvirus that can cause serious morbidity and mortality in immunocompromised or immune-immature individuals. A vaccine that induces immunity to CMV in these target populations is therefore highly needed. Previous attempts to generate efficacious CMV v...
Autores principales: | Pardieck, Iris N., van Duikeren, Suzanne, Veerkamp, Dominique M. B., Brasem, Dena J., Redeker, Anke, van Bergen, Jeroen, Han, Wanda, Ossendorp, Ferry, Zondag, Gerben, Arens, Ramon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828907/ https://www.ncbi.nlm.nih.gov/pubmed/35154089 http://dx.doi.org/10.3389/fimmu.2022.680559 |
Ejemplares similares
-
A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control
por: Tondini, Elena, et al.
Publicado: (2019) -
Cytomegalovirus infection and progressive differentiation of effector-memory T cells
por: Pardieck, Iris N., et al.
Publicado: (2018) -
The Breadth of Synthetic Long Peptide Vaccine-Induced CD8(+) T Cell Responses Determines the Efficacy against Mouse Cytomegalovirus Infection
por: Panagioti, Eleni, et al.
Publicado: (2016) -
A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection
por: Pardieck, Iris N., et al.
Publicado: (2022) -
FcγRI expression on macrophages is required for antibody-mediated tumor protection by cytomegalovirus-based vaccines
por: Benonisson, Hreinn, et al.
Publicado: (2018)